← Back to Search

PrEP Rapid Access for HIV Prevention in Substance Users

N/A

Waitlist Available

Led By Sabrina Assoumou, MD MPH

Research Sponsored by Boston Medical Center

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up through study completion, an average of 1 year

Awards & highlights

Study Summary

This trial will offer immediate access to PrEP through point-of-care HIV self-testing, viral load confirmation, and on-site PrEP prescriptions at a Mobile Prevention Services Van to increase uptake among people who inject drugs.

Who is the study for?

This trial is for English-speaking individuals who have used non-prescribed injectable drugs in the last 90 days and are willing to share their medical records. It's not for pregnant women, those planning to move away from Boston within six months, current PrEP users with regular check-ups, HIV-positive individuals, or anyone with intentions of self-harm or harm to others.Check my eligibility

What is being tested?

The 'Rapid PrEP Access' intervention at the Victory Program aims to test if people who use drugs find it easy and acceptable to use a one-time HIV self-testing service. The study will assess how well participants accept this approach and its practicality.See study design

What are the potential side effects?

Since this trial focuses on feasibility and acceptability of HIV self-testing rather than medication side effects, there may be no direct physical side effects. However, emotional or psychological impacts due to learning one's HIV status could occur.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ through study completion, an average of 1 year

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~through study completion, an average of 1 year

This trial's timeline: 3 weeks for screening, Varies for treatment, and through study completion, an average of 1 year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Acceptability of PrEP rapid Access

Number of participants enrolled

Secondary outcome measures

Number of participants interested in initiating PrEP

Number of participants who perform HIV self-test

Trial Design

1Treatment groups

Experimental Treatment

Group I: PrEP Rapid AccessExperimental Treatment3 Interventions

Participants who are at risk of HIV and being seen at the Victory Program's Mobile Prevention Services Van.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Boston Medical CenterLead Sponsor

382 Previous Clinical Trials

869,359 Total Patients Enrolled

Victory ProgramsUNKNOWN

Sabrina Assoumou, MD MPHPrincipal InvestigatorBoston Medical Center, Infectious Diseases

Media Library

PrEP Rapid Access Clinical Trial Eligibility Overview. Trial Name: NCT05528562 — N/A

Pre-Exposure Prophylaxis Research Study Groups: PrEP Rapid Access

Pre-Exposure Prophylaxis Clinical Trial 2023: PrEP Rapid Access Highlights & Side Effects. Trial Name: NCT05528562 — N/A

PrEP Rapid Access 2023 Treatment Timeline for Medical Study. Trial Name: NCT05528562 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any vacancies available in this investigation for individuals?

"According to clinicaltrials.gov, the study is no longer accepting patients into its trial as of November 9th 2022. Initially posted on December 1st 2022, this research endeavour has concluded recruitment; however, there are still 316 other trials searching for participants at this moment in time."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Pre-exposure Prophylaxis (PrEP) Rapid Access

2023. "Pre-exposure Prophylaxis (PrEP) Rapid Access". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05528562.